Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Daily

Download Data

Alpha Tau Medical Ltd Earnings Yield on June 03, 2024: -15.77%

Alpha Tau Medical Ltd Earnings Yield is -15.77% on June 03, 2024, a -216.56% change year over year. The earnings yield represents the earnings per share as a percentage of the market price per share. It is calculated by dividing income after tax by the market capitalization. This ratio provides insight into the relative value of a company's earnings in relation to its market value. A higher earnings yield may indicate a relatively undervalued stock.

Alpha Tau Medical Ltd 52-week high Earnings Yield is -4.96% on June 06, 2023, which is 68.54% above the current Earnings Yield.
Alpha Tau Medical Ltd 52-week low Earnings Yield is -17.81% on May 02, 2024, which is -12.92% below the current Earnings Yield.
Alpha Tau Medical Ltd average Earnings Yield for the last 52 weeks is -11.40%.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends